Case Reports in Oncological Medicine

Scope & Guideline

Advancing oncology through shared clinical insights.

Introduction

Explore the comprehensive scope of Case Reports in Oncological Medicine through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Case Reports in Oncological Medicine in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2090-6706
PublisherHINDAWI LTD
Support Open AccessYes
Country-
TypeJournal
Convergefrom 2014 to 2017 (coverage discontinued in Scopus)
AbbreviationCASE REP ONCOL MED / Case Rep. Oncol. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The journal 'Case Reports in Oncological Medicine' focuses on the documentation and analysis of unique and rare cases in the field of oncology. The journal serves as a platform for sharing clinical experiences that contribute to the understanding of cancer diagnosis, treatment, and management. Its core areas of research and methodologies include:
  1. Clinical Case Reports:
    The journal emphasizes detailed clinical case reports that provide insights into unique presentations or rare manifestations of cancers, enhancing the knowledge base of oncologists.
  2. Multidisciplinary Approaches:
    It showcases cases involving multidisciplinary treatment strategies, highlighting the importance of collaboration among various specialists in managing complex oncological cases.
  3. Innovative Treatment Strategies:
    The journal frequently discusses novel therapies and their outcomes, including the use of targeted therapies, immunotherapies, and other emerging treatment modalities.
  4. Pathological Insights:
    Pathological analyses and findings play a crucial role in the reports, often leading to discussions on the implications for diagnosis and prognosis.
  5. Patient-Centered Outcomes:
    There is a consistent focus on patient outcomes, including quality of life and treatment efficacy, which are critical for informing future clinical practices.
The journal is responsive to the evolving landscape of oncological medicine, with several emerging themes that reflect current trends and advancements in the field. These themes indicate areas of increasing research interest and clinical relevance:
  1. Immunotherapy and Checkpoint Inhibitors:
    There is a growing number of case reports addressing the effects and complications of immunotherapy, particularly immune checkpoint inhibitors, highlighting their significance in modern cancer treatment.
  2. Genetic and Molecular Insights:
    Emerging cases that delve into the genetic and molecular underpinnings of cancers are on the rise, reflecting a shift towards personalized medicine and targeted therapies.
  3. Rare and Uncommon Tumors:
    The focus on rare tumor types and unusual presentations is trending, providing critical insights into less understood malignancies and their management.
  4. Multimodal Treatment Approaches:
    Increasingly, reports are showcasing combined treatment modalities (e.g., surgery, chemotherapy, and radiotherapy), emphasizing a comprehensive approach to complex oncology cases.
  5. Patient-Specific Treatment Responses:
    There is a trend towards documenting individual patient responses to specific treatments, which is vital for understanding the variability of treatment efficacy and guiding future clinical decisions.

Declining or Waning

While 'Case Reports in Oncological Medicine' maintains a robust focus on rare and unique oncology cases, certain themes have shown a decline in recent publications. These waning scopes highlight areas that may be losing prominence or evolving due to advancements in research and treatment:
  1. Traditional Chemotherapy Case Reports:
    There has been a noticeable decline in the publication of case reports solely focusing on traditional chemotherapy regimens, as newer treatment modalities gain traction and become the focus of clinical discussion.
  2. Palliative Care Case Studies:
    Fewer case reports are dedicated to palliative care approaches, suggesting a shift towards curative or innovative treatment discussions in oncology.
  3. Basic Science Reports:
    Reports that primarily focus on basic science or laboratory findings related to oncology are less common, indicating a preference for clinical applications and case-related insights.
  4. Epidemiological Studies:
    There is a decrease in the publication of case reports centered around epidemiological data, possibly as more comprehensive studies and reviews are published elsewhere.
  5. Generalized Cancer Types:
    The journal has shifted away from more generalized cancer types, focusing instead on rarer cancers and unique presentations that offer novel insights.

Similar Journals

Current Problems in Cancer: Case Reports

Transforming patient care through diverse oncology perspectives.
Publisher: ELSEVIERISSN: 2666-6219Frequency: 2 issues/year

Current Problems in Cancer: Case Reports is a prominent scholarly journal published by Elsevier, focusing on critical case reports within the field of oncology. Since its transition to Open Access in 2020, it has enhanced accessibility for researchers and healthcare professionals seeking to share and discuss unique clinical scenarios and insights that advance cancer treatment and patient care. Operating from the United States, this journal aims to address the important and often intricate challenges faced in oncology, facilitating a platform for knowledge exchange and the exploration of new perspectives in cancer management. Despite its current Q4 category ranking in the 2023 oncology category of Scopus with a rank of #359/404, its goal is to enrich the academic discourse by featuring diverse case reports and promoting evidence-based practices. As the journal evolves from 2021 to 2024, it seeks to impact the field by inviting researchers, professionals, and students to contribute their findings, ultimately fostering a collaborative environment for tackling the complexities of cancer.

Case Reports in Nephrology and Dialysis

Advancing renal insights through shared experiences.
Publisher: KARGERISSN: 2296-9705Frequency: 3 issues/year

Case Reports in Nephrology and Dialysis, published by KARGER, is a vital peer-reviewed journal dedicated to the dissemination of case reports and innovative findings in the fields of nephrology and dialysis. Since its inception in 2015, this Open Access journal has aimed to foster knowledge exchange and improve patient outcomes through comprehensive case studies, clinical insights, and recent advancements in renal healthcare. Based in Switzerland, the journal is poised to serve a global audience, accommodating research that spans diverse geographical and clinical contexts. Currently ranked in the Q3 category for nephrology in 2023, it underscores its burgeoning influence in the medical literature, despite its relatively nascent presence. As a valuable resource for researchers, healthcare professionals, and students, it provides a platform for sharing unique cases that enrich the understanding of complex renal issues and challenges faced in dialysis. With an emphasis on high-quality, accessible research, Case Reports in Nephrology and Dialysis is committed to advancing nephrology and dialysis practices through collaboration and knowledge sharing.

Case Reports in Gastroenterology

Elevating clinical findings in gastroenterology.
Publisher: KARGERISSN: Frequency: 3 issues/year

Case Reports in Gastroenterology, published by KARGER, is a dedicated open-access journal that has been providing an invaluable platform for the dissemination of important clinical findings and innovative treatments in the field of gastroenterology since its establishment. With its E-ISSN of 1662-0631, this journal fosters academic exchange and research development by publishing case reports that highlight novel insights and practical applications in gastrointestinal medicine. The journal is significant within its category, holding a Q3 quartile ranking as of 2023 in gastroenterology, and is positioned at rank #121 out of 167 in Scopus’ classification for gastroenterology medicine. With a convergence period from 2010 to 2024, researchers, professionals, and students are encouraged to contribute and access high-quality, peer-reviewed content. Alongside its commitment to open access, which enhances visibility and accessibility to vital research, Case Reports in Gastroenterology remains a respected resource for those seeking to expand their knowledge and engage with contemporary developments in the gastroenterological community.

Journal of Kidney Cancer and VHL

Catalyzing progress in VHL research and treatment.
Publisher: CODON PUBLICATIONSISSN: 2203-5826Frequency: 4 issues/year

The Journal of Kidney Cancer and VHL stands as a leading platform for disseminating cutting-edge research in the field of renal oncology, particularly focused on kidney cancer and Von Hippel-Lindau (VHL) disease. Published by CODON PUBLICATIONS since its inception, this Open Access journal, with ready accessibility since 2014, aims to foster knowledge exchange and collaboration among researchers, clinicians, and healthcare professionals dedicated to improving outcomes for patients with kidney cancer. With an ISSN of 2203-5826, this journal serves as a vital resource in the academic community, encouraging submissions that span various topics, including epidemiology, treatment modalities, and innovative therapeutic strategies. By providing unrestricted access to its content, the Journal of Kidney Cancer and VHL promotes inclusive participation in the global dialogue surrounding these critical health challenges, ensuring that the latest findings reach all corners of the scientific community.

Translational Oncology

Innovating Tomorrow's Cancer Therapies Today
Publisher: ELSEVIER SCIENCE INCISSN: 1936-5233Frequency: 6 issues/year

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

World Journal of Clinical Cases

Elevating Clinical Excellence through Insightful Research
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 2307-8960Frequency: 36 issues/year

The World Journal of Clinical Cases is a premier publication dedicated to the dissemination of high-quality clinical research and case reports that contribute to enhancing clinical practice and patient care. Established by BAISHIDENG PUBLISHING GROUP INC, this journal has established itself as a significant resource in the field of medicine, achieving a Q3 ranking in the miscellaneous category as of 2021 and maintaining a competitive position with a Scopus rank of #443/826. With coverage from 2018 to 2023, the journal focuses on diverse aspects of general medicine, promoting innovative research and clinical insights. Although it is not listed as open access, researchers and practitioners can benefit from its focused scope, aiding in knowledge advancement and fostering collaborative efforts in the medical community. The journal's commitment to quality and integrity makes it an essential platform for professionals seeking to stay informed about the latest clinical developments.

Case Reports in Dermatology

Elevating clinical practice with open access case studies.
Publisher: KARGERISSN: 1662-6567Frequency: 3 issues/year

Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.

Case Reports in Oncology

Advancing Oncology Through Case Studies
Publisher: KARGERISSN: 1662-6575Frequency: 3 issues/year

Case Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.

International Cancer Conference Journal

Connecting Ideas, Inspiring Change in Cancer Research
Publisher: SPRINGER INT PUBL AGISSN: 2192-3183Frequency: 4 issues/year

International Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.

Acta Oto-Laryngologica Case Reports

Bridging Clinical Practice and Research in Otolaryngology
Publisher: TAYLOR & FRANCIS LTDISSN: 2377-2484Frequency: 1 issue/year

Acta Oto-Laryngologica Case Reports, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to the dissemination of high-quality case reports in the field of otolaryngology. Since its inception in 2016, this journal has been a vital platform for researchers and clinicians to share unique clinical insights and advancements related to ear, nose, and throat disorders. With an ISSN of 2377-2484, it provides unparalleled access to the latest findings, facilitating collaboration and innovation among professionals in otolaryngology. The journal's commitment to open-access publishing ensures that critical research is freely available to a global audience, enhancing the visibility and impact of its contributors' work. Researchers, practitioners, and students in the medical field will find valuable resources and case studies that not only contribute to professional development but also address current challenges in patient care.